Roche Xeloda Colorectal Use Clears FDA; Promotions Must Cite Camptosar

07 May 2001

• By The Pink Sheet

Roche will study Xeloda in combination with Pharmacia's Camptosar in colorectal cancer patients following FDA approval of Xeloda April 30 for use in metastatic colorectal cancer patients.

Roche Xeloda Colorectal Use Clears FDA; Promotions Must Cite Camptosar

More from Archive

More from Pink Sheet